ストックスクリーナーアプリを入手
13.20
0.53%
-0.07
前日終値:
$13.27
開ける：
$13.12
24時間の取引高:
2.05M
Relative Volume:
1.20
時価総額：
$2.20B
収益：
$3.47B
当期純損益:
$668.83M
株価収益率:
3.2896
EPS:
4.0127
ネットキャッシュフロー:
$253.46M
1週間 パフォーマンス:
-3.72%
1か月 パフォーマンス:
+1.93%
6か月 パフォーマンス:
-17.16%
1年 パフォーマンス:
-10.02%
1日の値動き範囲:
$13.12
$13.25
1週間の範囲:
$13.12
$13.85
52週間の値動き範囲:
$12.50
$16.89
Dr Reddys Laboratories Ltd Adr Stock (RDY) Company Profile
RDY を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
RDY
Dr Reddys Laboratories Ltd Adr
|
13.20 | 2.20B | 3.47B | 668.83M | 253.46M | 4.0127 |
|
ZTS
Zoetis Inc
|
163.11 | 73.07B | 9.26B | 2.49B | 2.30B | 5.47 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.05 | 47.43B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
HLN
Haleon Plc Adr
|
10.24 | 45.72B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
15.08 | 17.28B | 16.54B | -1.64B | 749.00M | -1.45 |
|
ITCI
Intra Cellular Therapies Inc
|
131.81 | 14.03B | 612.78M | -86.37M | -62.91M | -0.87 |
Dr Reddys Laboratories Ltd Adr Stock (RDY) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-12-19 | ダウングレード | Nomura | Buy → Neutral |
| 2024-01-11 | ダウングレード | Jefferies | Buy → Underperform |
| 2023-08-29 | ダウングレード | HSBC Securities | Buy → Hold |
| 2023-05-18 | ダウングレード | Bernstein | Outperform → Mkt Perform |
| 2023-03-17 | アップグレード | BofA Securities | Neutral → Buy |
| 2023-01-30 | 開始されました | JP Morgan | Underweight |
| 2022-11-14 | ダウングレード | Credit Suisse | Neutral → Underperform |
| 2022-01-03 | 再開されました | BofA Securities | Neutral |
| 2021-07-27 | ダウングレード | Credit Suisse | Outperform → Neutral |
| 2021-02-02 | アップグレード | Barclays | Equal Weight → Overweight |
| 2020-09-18 | アップグレード | BofA Securities | Neutral → Buy |
| 2020-09-18 | アップグレード | Investec | Sell → Hold |
| 2020-01-28 | ダウングレード | CLSA | Buy → Outperform |
| 2020-01-27 | ダウングレード | CLSA | Buy → Outperform |
| 2020-01-09 | アップグレード | Citigroup | Sell → Buy |
| 2019-11-04 | ダウングレード | BofA/Merrill | Buy → Neutral |
| 2019-09-04 | アップグレード | Credit Suisse | Underperform → Outperform |
| 2019-07-01 | アップグレード | Macquarie | Neutral → Outperform |
| 2019-06-20 | 開始されました | Deutsche Bank | Hold |
| 2019-06-11 | 開始されました | Barclays | Equal Weight |
| 2019-05-20 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2019-02-19 | アップグレード | CLSA | Outperform → Buy |
| 2019-01-17 | ダウングレード | Citigroup | Neutral → Sell |
| 2017-09-21 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2017-08-31 | アップグレード | CLSA | Underperform → Outperform |
| 2017-07-28 | ダウングレード | CLSA | Underperform → Sell |
| 2016-07-27 | ダウングレード | HSBC Securities | Hold → Reduce |
| 2016-07-27 | ダウングレード | Jefferies | Hold → Underperform |
| 2016-02-10 | アップグレード | Credit Agricole | Underperform → Buy |
| 2015-11-10 | ダウングレード | Citigroup | Buy → Neutral |
すべてを表示
Dr Reddys Laboratories Ltd Adr (RDY) 最新ニュース
American Healthcare REIT Inc (AHR) Stock: A Year of Decreases and Increases - The InvestChronicle
Asian Equities Traded in the US as ADRs Rise in Tuesday Trading - MSN
Asian Equities Traded in the US as American Depositary Receipts Decline in Tuesday Trading - TradingView
Weekly Stock Grader Analysis: Upgrades & Downgrades on Top Blue-Chip Stocks - InvestorPlace
Asian Equities Traded in the US as American Depositary Receipts Lower in Friday Trading - TradingView
Infosys, Wipro, TCS, other IT stocks fall up to 3% after Accenture Q2 results. Details here - Mint
Infosys, Wipro ADRs drop over 3% on NYSE after Accenture hikes full-year revenue guidance to 5-7% on AI boom - Mint
Asian Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading - TradingView
Asian Equities Traded in the US as American Depositary Receipts Rise Slightly in Wednesday Trading - TradingView
Asian Equities Traded in the US as American Depositary Receipts Track Sharply Lower in Tuesday Trading - TradingView
Asian Equities Traded in the US as American Depositary Receipts Open Week Sharply Higher - TradingView
Bioengineered Protein Drugs Market Size to Cross USD 672.7 Billion by 2034, Growing at a CAGR of 6.2% - GlobeNewswire Inc.
Asian Equities Traded in the US as American Depositary Receipts Lower in Thursday Trading - TradingView
Asian Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading - TradingView
Best upcoming stock splits and reverse splits 2024 - InvestorsObserver
Asian Equities Traded in the US as American Depositary Receipts Higher in Tuesday Trading - TradingView
Asian Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Up 1.5% for Week - TradingView
Is TG Therapeutics Inc (NASDAQ: TGTX) A Good Investment For New Investors Now? - Stocks Register
Senores Pharmaceuticals Shares: Rises 7%, acquires 14 ANDAs from Dr. Reddy’s - BusinessLine
Rhumbline Advisers Grows Position in Dr. Reddy's Laboratories Limited (NYSE:RDY) - MarketBeat
Dr. Reddy's Laboratories Ltd. Sponsored ADR to Host Earnings Call - ACCESS Newswire
Stocks to watch: Bharti Airtel, Wipro, Coforge, Dr Reddy’s, Vakrangee among shares to remain in focus today - Mint
Share Market Update – Dr Reddy Share Price Target 2025 - LDCCBank
Asian Equities Traded in the US as American Depositary Receipts Tumble in Monday Trading - TradingView
Alvotech heldur kynningarfund fyrir fjárfesta 27. mars 2025, eftir birtingu uppgjörs fyrir árið 2024 og fjórða ársfjórðung - GlobeNewswire Inc.
Asian Equities Traded in the US as American Depositary Receipts Rise Sharply in Friday Trading, Up 2.2% for Week - MSN
Its Stock Has Paid Off Big Time For Dr. Reddy’s Laboratories Ltd. ADR - SETE News
Marshall Wace, DE Shaw, Millennium Helped Drive China ADR Surges - Mint
Lester Murray Antman dba SimplyRich Increases Stock Position in Dr. Reddy's Laboratories Limited (NYSE:RDY) - MarketBeat
Asian Equities Traded in the US as American Depositary Receipts Rise Sharply in Friday Trading; End Week Up 2% - TradingView
Asian Equities Traded in the US as American Depositary Receipts Higher in Thursday Trading - TradingView
Indian ADRs Alert! Why Infosys, Wipro, HDFC Bank, ICICI Bank, Dr Reddy's Lab Will Be In Focus On February 13? - Goodreturns
Taking on analysts’ expectations and winning: Dr. Reddy’s Laboratories Ltd. ADR (RDY) - SETE News
Dr. Reddy’s Laboratories Ltd. ADR [NYSE: RDY] Sees Decrease in Stock Value - Knox Daily
Nothing is Better Than Sociedad Quimica Y Minera de Chile S.A. ADR (SQM) stock at the moment - SETE News
Ecolab, Inc (ECL) expanding its growth trajectory ahead - SETE News
A look into Golar Lng (GLNG)’s deeper side - SETE News
Altria Group Inc [NYSE: MO] Sees Increase in Stock Value - Knox Daily
Moody’s Corp [MCO] Shares Jump Approximately 26.66% Over the Year - Knox Daily
Understanding the 1.67% Volatility Levels of Dr. Reddy’s Laboratories Ltd. ADR’s (RDY) Stock in the Past 30 Days - The News Heater
LLY Stock Quote Price and Forecast - CNN
Dr. Reddy’s Faces GST Penalty, Evaluates Appeal - TipRanks
Of 5 billionaires contesting today’s Delhi elections, 3 are from BJP: Know their net worths - Mint
Dr Reddy's Labs shares slide 6% post Q3 results. Should you buy, sell, or hold? - The Economic Times
Dr. Reddy’s Labs ADR earnings missed by $0.02, revenue fell short of estimates - Investing.com
Coupang Inc (NYSE: CPNG): A Blank Check? - Stocks Register
CLSA cuts Dr. Reddy's stock rating to Underperform - Investing.com India
Dr Reddy's Labs Q3 Preview: Lower Revlimid contribution, subdued US sales to dent earnings growth - Moneycontrol
Week Ahead: Q3 Results, FII flow, Donald Trump inauguration, global cues among key market triggers for Sensex, Nifty - Mint
Why Wipro share price may have a gap-up opening on Monday? EXPLAINED - Mint
Wipro ADR rises 4% on NYSE after IT major’s net profit shoots 24% YoY to surpass Street estimates in Q3FY25 - Mint
Dr Reddys Laboratories Ltd Adr (RDY) 財務データ
収益
当期純利益
現金流量
EPS
3.70%
0.05%
大文字化:
|
ボリューム (24 時間):